Literature DB >> 24507479

14-Deoxyandrographolide alleviates ethanol-induced hepatosteatosis through stimulation of AMP-activated protein kinase activity in rats.

Samir Mandal1, Sibabrata Mukhopadhyay2, Sukdeb Bandhopadhyay2, Gargi Sen3, Tuli Biswas4.   

Abstract

Andrographis paniculata (AP) is a traditional medicinal plant of Ayurveda. It grows widely in Asia and is prescribed in the treatment of liver diseases. Here we have investigated the beneficial role of 14-deoxyandrographolide (14-DAG), a bioactive diterpenoid from AP, against alcoholic steatosis in rats. 14-DAG was extracted from aerial parts (leaves and stems) of AP. Rats were fed with ethanol for 8 weeks. Animals were treated with 14-DAG during the last 4 weeks of ethanol treatment. In vitro studies were undertaken in a human hepatocellular liver carcinoma cell line culture. Hepatosteatosis was assessed from histopathological studies of liver sections. Acetyl-CoA, malonyl-CoA, and triglyceride contents were determined using commercially available kits. Fatty acid synthesis was evaluated from incorporation of 1-(14)C acetate. Regulation of fatty acid oxidation and lipogenesis were monitored with immunoblotting and immunoprecipitation studies. Ethanol exposure led to hepatotoxicity, as evident from the marked enhancement in the levels of AST and ALT. The values decreased almost to control levels in response to 14-DAG treatment. Results showed that ethanol feeding induced deactivation of AMP-activated protein kinase (AMPK) that led to enhanced lipid synthesis and decreased fatty acid oxidation, culminating in hepatic fat accumulation. Treatment with 14-DAG activated AMPK through induction of cyclic AMP-protein kinase A pathway. Activation of AMPK was followed by down-regulation of sterol regulatory element binding protein-1c, acetyl-CoA carboxylase, and fatty acid synthase, leading to suppression of lipogenesis. This was associated with up-regulation of sirtuin 1 and depletion of malonyl-CoA, in favor of increased fatty acid oxidation. 14-DAG controlled ethanol-induced hepatosteatosis by interfering with dysregulation of lipid metabolism. In conclusion, our results indicated that 14-DAG was capable of preventing the development of fatty liver through AMPK-mediated regulation of lipid metabolism. This finding supported the hepatoprotective role of 14-DAG, which might serve as a therapeutic option to alleviate hepatosteatosis in chronic alcoholism.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  14-Deoxyandrographolide; AMP-activated protein kinase; Ethanol; Hepatosteatosis; Lipid metabolism

Mesh:

Substances:

Year:  2014        PMID: 24507479     DOI: 10.1016/j.alcohol.2013.11.005

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  9 in total

Review 1.  Sirtuin 1 signaling and alcoholic fatty liver disease.

Authors:  Min You; Alvin Jogasuria; Charles Taylor; Jiashin Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

2.  Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.

Authors:  Diana V Avila; David F Barker; JingWen Zhang; Craig J McClain; Shirish Barve; Leila Gobejishvili
Journal:  J Pathol       Date:  2016-09       Impact factor: 7.996

Review 3.  Regulation of AMP-activated protein kinase by natural and synthetic activators.

Authors:  David Grahame Hardie
Journal:  Acta Pharm Sin B       Date:  2015-07-21       Impact factor: 11.413

Review 4.  Emerging roles of SIRT1 in fatty liver diseases.

Authors:  Ren-Bo Ding; Jiaolin Bao; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2017-07-06       Impact factor: 6.580

5.  Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway.

Authors:  Youn Ju Lee; Mi-Sun Shu; Jong-Yeon Kim; Yun-Hye Kim; Kyeong Hwa Sim; Woo Jung Sung; Jong Ryeol Eun
Journal:  PLoS One       Date:  2019-01-29       Impact factor: 3.240

6.  Rhodiola crenulata extract regulates hepatic glycogen and lipid metabolism via activation of the AMPK pathway.

Authors:  Kuen-Tze Lin; Shih-Wei Hsu; Feng-Yi Lai; Tsu-Chung Chang; Li-Shian Shi; Shih-Yu Lee
Journal:  BMC Complement Altern Med       Date:  2016-05-17       Impact factor: 3.659

7.  AMPK: a novel target for treating hepatic fibrosis.

Authors:  Zhenxing Liang; Tian Li; Shuai Jiang; Jing Xu; Wencheng Di; Zhi Yang; Wei Hu; Yang Yang
Journal:  Oncotarget       Date:  2017-07-19

8.  Gentiopicroside Ameliorates the Progression from Hepatic Steatosis to Fibrosis Induced by Chronic Alcohol Intake.

Authors:  Hong-Xu Yang; Yue Shang; Quan Jin; Yan-Ling Wu; Jian Liu; Chun-Ying Qiao; Zi-Ying Zhan; Huan Ye; Ji-Xing Nan; Li-Hua Lian
Journal:  Biomol Ther (Seoul)       Date:  2020-07-01       Impact factor: 4.634

Review 9.  The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism.

Authors:  Sha Li; Yu Xu; Wei Guo; Feiyu Chen; Cheng Zhang; Hor Yue Tan; Ning Wang; Yibin Feng
Journal:  Front Pharmacol       Date:  2020-03-24       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.